Shaperon

About:

Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.

Website: http://shaperon.com

Top Investors: Smilegate Investment, Yuanta Investment, BNK Venture Capital, POSCO CAPITAL, Albatross Investment

Description:

Total Funding Amount:

26B KRW

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2008-01-01

Founders:

Seung-Yong Seong

Number of Employees:

11-50

Last Funding Date:

2020-10-20

IPO Status:

Private

Industries: